David Michael Glanville Martin

Title: David Michael Glanville Martin: Innovator in Chemical Processes

Introduction

David Michael Glanville Martin is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of chemistry, particularly in the synthesis of quinazoline derivatives. With a total of five patents to his name, Martin's work has implications in pharmaceutical applications.

Latest Patents

One of Martin's latest patents involves a chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline. This invention relates to the manufacture of certain quinazoline derivatives and their pharmaceutically acceptable salts. The patent also covers processes for producing intermediates that are useful in the manufacture of these quinazoline derivatives. In particular, the invention focuses on chemical processes and intermediates that facilitate the production of the compound mentioned.

Career Highlights

Throughout his career, Martin has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Genzyme Corporation. His experience in these organizations has contributed to his expertise in chemical processes and innovation.

Collaborations

Martin has collaborated with notable professionals in his field, including Jorgen Blixt and Michael David Golden. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

David Michael Glanville Martin is a distinguished inventor whose contributions to chemical processes have advanced the field of pharmaceuticals. His innovative work continues to influence the synthesis of important compounds.